Page 220 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

196 Constantina Yiannakis, Lorna Ward and Matthew David Morgan

[114] Xu, P. C., Cui, Z., Chen, M., et al. Comparison of characteristics of natural
autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from
patients with microscopic polyangiitis. Rheumatology 2011; 50:1236-1243.

[115] Pendergraft, 3rd W., Preston, G., Shah, R., et al. Autoimmunity is triggered by cPR-
3(105-201), a protein complementary to human autoantigen proteinase-3. Nat. Med.
2004; 10:72-79.

[116] Yang, J., Bautz, D. J., Lionaki, S., et al. ANCA patients have T cells responsive to
complementary PR-3 antigen. Kidney Int. 2008; 74:1159-1169.

[117] Mellbye, O. J., Mollnes, T. E., Steen, L. S. IgG subclass distribution and complement
activation ability of autoantibodies to neutrophil cytoplasmic antigens (ANCA). Clin.
Immunol. Immunopathol. 1994; 70:32-39.

[118] Schmitt, W. H., Heesen, C., Csernok, E., et al. Elevated serum levels of soluble
interleukin-2 receptor in patients with Wegener's granulomatosis. Association with
disease activity. Arthritis Rheum. 1992; 35:1088-1096.

[119] Brouwer, E., Stegeman, C. A., Huitema, M. G., et al. T cell reactivity to proteinase 3
and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin. Exp.
Immunol. 1994; 98:448-453.

[120] Griffith, M. E., Coulthart, A., Pusey, C. D. T cell responses to myeloperoxidase (MPO)
and proteinase 3 (PR3) in patients with systemic vasculitis. Clin. Exp. Immunol. 1996;
103: 253-258.

[121] King, W. J., Brooks, C. J., Holder, R., et al. T lymphocyte responses to anti-neutrophil
cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-
associated systemic vasculitis and persist during disease remission. Clin. Exp. Immunol.
1998; 112:539-546.

[122] Berden, A. E., Kallenberg, C. G., Savage, C. O., et al. Cellular immunity in Wegener's
granulomatosis: characterizing T lymphocytes. Arthritis Rheum. 2009; 60:1578-1587.

[123] Abdulahad, W. H., Stegeman, C. A., van der Geld, Y. M., et al. Functional defect of
circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in
remission. Arthritis Rheum. 2007; 56:2080-2091.

[124] Morgan, M., Day, C., Piper, K., et al. Patients with Wegener's granulomatosis
demonstrate a relative deficiency and functional impairment of T-regulatory cells.
Immunology 2010; 130:64-73.

[125] Abdulahad, W. H., Stegeman, C. A., Limburg, P. C., et al. Skewed distribution of Th17
lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum.
2008; 58:2196-2205.

[126] Nogueira, E., Hamour, S., Sawant, D., et al. Serum IL-17 and IL-23 levels and
autoantigen-specific Th17 cells are elevated in patients with ANCA-associated
vasculitis. Nephrol. Dial. Transplant. 2010; 25:2209-2219.

[127] Chow, F. Y., Hooke, D., Kerr, P. G. Severe Intestinal Involvement In Wegener's
Granulomatosis. J. Gastroenterol. Hepatol. 2003; 18:749-750.

[128] Velden, J., Paust, H. J., Hoxha, E., et al. Renal IL-17 expression in human ANCA-
associated glomerulonephritis. Am. J. Physiol. Renal Physiol. 2012 Jun 15; 302: F1663-
1673.

[129] Csernok, E., Trabandt, A., Muller, A., et al. Cytokine profiles in Wegener's
granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation.
Arthritis Rheum. 1999; 42:742-750.

Complimentary Contributor Copy